SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-22-037110
Filing Date
2022-03-23
Accepted
2022-03-23 17:23:13
Documents
8
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm2210237d1_10k.htm 10-K 931083
2 EXHIBIT 4.3 tm2210237d1_ex4-3.htm EX-4.3 7122
3 EXHIBIT 21.1 tm2210237d1_ex21-1.htm EX-21.1 1461
4 EXHIBIT 31.1 tm2210237d1_ex31-1.htm EX-31.1 8150
5 EXHIBIT 31.2 tm2210237d1_ex31-2.htm EX-31.2 8056
6 EXHIBIT 32.1 tm2210237d1_ex32-1.htm EX-32.1 4255
7 EXHIBIT 32.2 tm2210237d1_ex32-2.htm EX-32.2 4269
8 GRAPHIC tm2210237d1_10kimage2.jpg GRAPHIC 2611
  Complete submission text file 0001104659-22-037110.txt   969140
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41264 | Film No.: 22763945
SIC: 2834 Pharmaceutical Preparations